Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-122 Lotion in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
NCT03987763Phase 4Active, not recruiting
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2019
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of IDP-122 Vehicle Lotion in plaque psoriasis, sponsored by Valeant Pharmaceuticals. Started Oct 2019; status: active, not recruiting.
02
Drugs
IDP-122 Vehicle Lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03987763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03987763.